Cargando…
Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support
BACKGROUND: Long-term prognosis in patients with fulminant myocarditis can be favorable; however, for 32–36% of patients, this condition becomes fatal during the acute stages despite the use of mechanical circulatory support. Other therapeutic options may be needed for patients in whom these conditi...
Autores principales: | Nakashima, Hiroshi, Umeyama, Yasuhiro, Minami, Kazutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700499/ https://www.ncbi.nlm.nih.gov/pubmed/23826449 http://dx.doi.org/10.12659/AJCR.889109 |
Ejemplares similares
-
Successful rescue of fulminant myocarditis with mechanical circulatory support and immunosuppression therapy: A case report
por: Zhou, Chi
Publicado: (2023) -
COVID-19 “Fulminant Myocarditis” Successfully Treated With Temporary Mechanical Circulatory Support
por: Salamanca, Jorge, et al.
Publicado: (2020) -
Mechanical Circulatory Support as a Bridge to Recovery in Fulminant Myocarditis
por: Iqbal, Yassir, et al.
Publicado: (2015) -
Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021) -
A case of COVID‐19‐associated fulminant myocarditis successfully treated with mechanical circulatory support
por: Asakura, Ryosuke, et al.
Publicado: (2022)